Skip to main content

Advertisement

Log in

Histoplasmosis in HIV-Infected Patients: Epidemiological, Clinical and Necropsy Data from a Brazilian Teaching Hospital

  • Original Article
  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Histoplasmosis occurs in 5–10% of HIV-infected patients in endemic areas and evolves to severe and disseminated infection with mortality rates over 50% in some regions. This report presents epidemiological, clinical and outcome data from HIV-infected patients with histoplasmosis confirmed by culture and/or at necropsy who were admitted to a Brazilian teaching hospital. Data from 65 patients were obtained from their respective medical and necropsy records. From 2005 to 2018, 36 HIV-infected patients were diagnosed with histoplasmosis confirmed by culture. At admission, most of these patients presented disseminated fungal infection, whereas 15 (41.7%) were simultaneously diagnosed with both HIV infection and histoplasmosis. Fever, weight loss, hepatosplenomegaly, respiratory and digestive symptoms were present in 86.2%, 50%, 44.4% and 41.7% of the patients, respectively. At admission, 24 patients had low CD4 T-cell count and high viral load values. Among the 30 patients who received antifungals, 16 (53.3%) were cured, 13 (43.3%) died, and one was lost to follow-up. Six patients died prior to therapy. From 1990 to 2018, 63 necropsies of patients with Histoplasma capsulatum infection were performed. Of these patients, 29 (46.0%) were HIV-infected individuals, including 21 (72.4%) who presented disseminated histoplasmosis and 21 (72.4%) who were diagnosed with histoplasmosis at necropsy. The epidemiological, clinical and outcome profiles presented herein are similar to those described elsewhere and reinforce the difficulties that are still present in limited-resource settings where advanced immunodeficiency, combined with severe fungal infection and late patient admissions, is related to poor outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hajjeh RA. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(Suppl 1):S108–10.

    Article  Google Scholar 

  2. McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis. 1997;24:1195–203.

    Article  CAS  Google Scholar 

  3. Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med. 1985;78:203–10.

    Article  CAS  Google Scholar 

  4. Couppié P, Sobesky M, Aznar C, et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis. 2004;38:134–8.

    Article  Google Scholar 

  5. Wheat LJ, Connolly-Stringfield P, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Med (Baltimore). 1990;69:361–74.

    Article  CAS  Google Scholar 

  6. Huber F, Nacher M, Aznar C, et al. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS. 2008;22(9):1047–53.

    Article  Google Scholar 

  7. Adenis A, Nacher M, Hanf M, et al. HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority. PLoS Negl Trop Dis. 2014;8(8):e3100.

    Article  Google Scholar 

  8. Nacher M, Adenis A, Mc Donald S, et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis. 2013;7:e2319.

    Article  Google Scholar 

  9. Cano-Torres JO, Olmedo-Reneaum A, Esquivel-Sánchez JM, et al. Progressive disseminated histoplasmosis in Latin America and the Caribbean in people receiving highly active antiretroviral therapy for HIV infection: a systematic review. Med Mycol. 2019;57(7):791–9.

    Article  Google Scholar 

  10. Prado M, Silva MB, Laurenti R, et al. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz. 2009;104(3):513–21.

    Article  Google Scholar 

  11. Teixeira TRA, Gracie RM, Monica SB, Francisco I. Social geography of AIDS in Brazil: identifying patterns of regional inequalities. Cadernos de Saúde Pública. 2014;30(2):259–71.

    Article  Google Scholar 

  12. Brazil. Health Ministry. Adherence to antiretroviral treatment in Brazil: a collection of studies from the ATAR project. Brasília, DF; 2010. (in Portuguese).

  13. Damasceno LS, Ramos AN, Alencar CH, et al. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a northeastern area of Brazil. Mycoses. 2014;57:406–13.

    Article  Google Scholar 

  14. De Oliveira RB, Atobe JH, Souza SA, de Castro Lima Santos DW. Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil. Mycopathologia. 2014;178:71–8.

    Article  Google Scholar 

  15. Brilhante RSN, Fechine MAB, Mesquita JRL, et al. Histoplasmosis in HIV positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates. Trans R Soc Trop Med Hyg. 2012;106:484–8.

    Article  Google Scholar 

  16. Mora DJ, dos Santos CT, Silva-Vergara ML. Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG Brazil. Mycoses. 2008;51:136–40.

    Article  Google Scholar 

  17. Daher EF, Silva GB Jr, Barros FAS, Takeda CFV, Mota RMS, Arau MHA. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Int Health. 2007;12:1108–15.

    Article  Google Scholar 

  18. Borges AS, Ferreira MS, Silvestre MTA, Nishioka SA, Rocha A. Histoplasmose em pacientes imunossuprimidos: estudo de 18 casos Observados em Uberlândia, MG. Rev Soc Bras Med Trop. 1997;30(2):119–24.

    Article  CAS  Google Scholar 

  19. Hui AN, Koss MN, Meyer PR. Necropsy findings in acquired immunodeficiency syndrome: a comparison of premortem diagnoses with postmortem diagnoses with postmortem findings. Hum Pathol. 1984;15:670–6.

    Article  CAS  Google Scholar 

  20. Eza D, Cerrillo G, Moore DA, et al. Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol Res Pract. 2006;202(11):767–75.

    Article  Google Scholar 

  21. Antinori S, Nebuloni M, Magni C, et al. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol. 2009;132(2):221–7.

    Article  Google Scholar 

  22. Centers for Disease Control (CDC). Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. MMWR Morb Mortal Wkly Rep. 1985; 34: 373–75.

  23. Nacher M, Adenis A, Adriouch L, et al. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg. 2011;84:239–40.

    Article  Google Scholar 

  24. Samayoa B, Roy M, Ahlquist Cleveland A, et al. High mortality and coinfection in a prospective cohort of human immunodeficiency virus/acquired immune deficiency syndrome patients with histoplasmosis in Guatemala. Am J Trop Med Hyg. 2017;97:42–8.

    Article  Google Scholar 

  25. Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis. 2005;40:1199–202.

    Article  Google Scholar 

  26. Caceres DH, Adenis A, de Souza JVB, et al. The manaus declaration: current situation of histoplasmosis in the Americas, report of the II regional meeting of the international histoplasmosis advocacy group. Curr Fungal Infect Rep. 2019;13:244–9.

    Article  Google Scholar 

  27. Pontes LB, Leitão TD, Lima GG, Gerhard ES, Fernandes TA. Características clínico-evolutivas de 134 pacientes com histoplasmose disseminada associada a SIDA no Estado do Ceará. Rev Soc Bras Med Trop. 2010;43(1):27–31.

    Article  Google Scholar 

  28. Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Many WJ Jr. Histoplasmosis in HIV- infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62:151–6.

    Article  Google Scholar 

  29. Tobon AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and nonhuman immunodeficiency virus-infected individuals. AmJ Trop Med Hyg. 2005;73:576–82.

    Article  Google Scholar 

  30. Karimi K, Wheat LJ, Connolly P, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis. 2002;186(11):1655–60.

    Article  Google Scholar 

  31. Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis. 2001;32:1215–20.

    Article  CAS  Google Scholar 

  32. Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis. 2000;30:877–81.

    Article  CAS  Google Scholar 

  33. Souza SL, Feitoza PV, Araújo JR, Andrade RV, Ferreira LC. Causes of death among patients with acquired immunodeficiency syndrome autopsied at the Tropical Medicine Foundation of Amazonas. Rev Soc Bras Med Trop. 2008;41:247–51.

    Article  Google Scholar 

  34. Cury PM, Pulido CF, Furtado VM, da Palma FM. Autopsy findings in AIDS patients from a reference hospital in Brazil: analysis of 92 cases. Pathol Res Pract. 2003;199(12):811–4.

    Article  Google Scholar 

  35. Falci DR, Pasqualotto AC. Clinical mycology in Latin America and the Caribbean: a snapshot of diagnostic and therapeutic capabilities. Mycoses. 2019;62(4):368–73.

    Article  Google Scholar 

Download references

Acknowledgements

The financial support to FAPEMIG has been acknowledged (Grant: APQ02633-16).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario León Silva-Vergara.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Handling Editor: Celia Maria de Almeida Soares.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Damasceno-Escoura, A.H., Mora, D.J., Cardeal, A.C. et al. Histoplasmosis in HIV-Infected Patients: Epidemiological, Clinical and Necropsy Data from a Brazilian Teaching Hospital. Mycopathologia 185, 339–346 (2020). https://doi.org/10.1007/s11046-020-00435-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-020-00435-y

Keywords

Navigation